Moreover, EGCG also resulted in a dose-dependent increase in the Bax/Bcl-2 ratio that favors apoptosis in NPC cell lines (CNE-2 and 5-8F) (Figures 2D–I). This evidence concerns the gene BCL2 and nasopharyngeal carcinoma.